6 things to know about Isto Biologics

Shayna Korol -   Print  |

Isto Biologics is an orthobiologics company that develops spine and orthopedic solutions.

Here are six things to know:

1. The company's novel biosynthetic bone graft extender and substitute InQu are designed to promote bone formation in orthopedic procedures and spinal fusions.

2. Study results published in Frontiers in Surgery demonstrated that InQu supports significantly faster spinal fusion compared to beta-tricalcium phosphate and is associated with higher overall fusion rates at 12-months.

3. The company's Influx trabecular bone graft is a natural material designed to provide osteoinductivity and promote cell ingrowth.

4. Isto Biologics also manufactures the Magellan autologous platelet separator, Lightning aspiration needle and CellPoint concentrate bone marrow aspirate system.

5. The company provides blood management services.

6. In 2017, Isto Biologics acquired Progenicare, a medical sales and service company.

More articles on biologics:
Biologics may reduce work & activity impairment in axial spondyloarthritis patients, study shows: 4 things to know
Vericel appoints CMO: 3 details
17 key players in the global spine biologics market


© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers